EarSmartAI Targets $5B Pediatric Ear Infection Market with AI-Powered Diagnostic Platform, Secures Pre-Seed Investment, Names New CEO
Ear infections are the leading cause of pediatric office visits and antibiotic prescriptions in the US, with over 15 million annual cases and $5 billion in healthcare costs. With a projected pediatrician shortage of over 25,000 by 2030, scalable diagnostic solutions are urgently needed.To address this growing healthcare challenge, Boomerang Ventures announced a $250,000 pre-seed investment in EarSmartAI, a portfolio company developing an...
Read more








